SensUs 2019 challenged student teams to develop innovative biosensing systems for the measurement of adalimumab, a biological drug that is prescribed to patients suffering from rheumatoid arthritis (RA). RA affects around 1% of the world population. Measurement of adalimumab concentrations will enable more efficient and effective management of the disease.